# Efficacy and Safety of Bupropion for Treatment of Adolescent Smoking

> **NCT00248118** · PHASE2,PHASE3 · TERMINATED · sponsor: **National Institute on Drug Abuse (NIDA)** · enrollment: 72 (actual)

## Conditions studied

- Tobacco Dependence

## Interventions

- **DRUG:** Bupropion

## Key facts

- **NCT ID:** NCT00248118
- **Lead sponsor:** National Institute on Drug Abuse (NIDA)
- **Sponsor class:** NIH
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2005-01
- **Primary completion:** 2007-08
- **Final completion:** 2008-05
- **Target enrollment:** 72 (ACTUAL)
- **Why stopped:** PI left NIH
- **Last updated:** 2016-09-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00248118

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00248118, "Efficacy and Safety of Bupropion for Treatment of Adolescent Smoking". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT00248118. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*